<DOCUMENT>
<TYPE>EX-10.43
<SEQUENCE>4
<FILENAME>a2106012zex-10_43.htm
<DESCRIPTION>EXHIBIT 10.43
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#03BOS1451_3">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="ke1451_exhibit_10.43"> </A>
<A NAME="toc_ke1451_1"> </A>
<BR></FONT><FONT SIZE=2><B>EXHIBIT 10.43    <BR>  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>May&nbsp;28<SUP>th</SUP>,
2002 </FONT></P>

<P><FONT SIZE=2>Andrew
Uprichard, MD<BR>
92 Bullard St.<BR>
Sherborn, MA 01770 </FONT></P>

<P><FONT SIZE=2>Dear
Andrew, </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
am pleased to offer you the position of Chief Operating Officer reporting to myself at a bi-weekly rate of $11,153.85, which annualizes to $290,000 per year. For the first
year only (August&nbsp;1, 2002 though December&nbsp;31<SUP>st</SUP>, 2002), we will pay your cash bonus as a signing bonus of $25,000. For 2003 and beyond, your bonus target will be 20%,
subject to being an employee in good standing. Compensation is reviewed every January for all employees and is subject to performance-based increases. Your first review will be in January of 2003. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employment
at ArQule is at-will and is contingent upon your execution of the company's standard Non-Disclosure&nbsp;&amp; Inventions Agreement and verification of
authorization to work in the United States. In the event of termination without cause, (cause including, but not being limited to, failure to perform duties, refusal to follow reasonable instructions,
dishonesty, moral turpitude or breach of confidentiality) or in the event of a change in control resulting in the scope of your responsibilities being substantially reduced, you will be eligible to
receive 12&nbsp;months of salary and benefits. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the approval of the ArQule Board of Directors, you would also receive 125,000-150,000 options to purchase common stock of ArQule,&nbsp;Inc. These options would
vest at a rate of twenty-five percent annually commencing on the first anniversary of your employment with ArQule. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
and your dependents are entitled to ArQule's comprehensive health package including medical and dental. You are also provided life insurance at two times your annual salary up to
$300,000 and long and short-term disability insurance. In addition, you will receive four weeks of paid leave, which will be
accrued on a monthly basis. You will also be eligible to enroll in our company sponsored 401K Plan on the first day of any quarter. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ArQule
is an organization that is building an outstanding reputation for innovation in Drug Discovery. Credit for this goes to every one of our employees. We look forward to you
accepting our offer and becoming part of the ArQule Team as of July&nbsp;22, 2002. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you need further information regarding this offer or any other aspect of employment at ArQule feel free to reach me either by phone (781)-994-3311 or via email
at shill@arqule.com </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
best regards, </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="47%"><FONT SIZE=2><BR>
/s/ Stephen A. Hill<BR>
Stephen Hill<BR>
Chief Executive Officer, ArQule, Inc.</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="46%"><FONT SIZE=2><BR>
Accepted by: /s/ Andrew Uprichard<BR>
Andrew Uprichard<BR></FONT>
</TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2106012",CP="ARQULE",DN="3",CHK=287268,FOLIO='blank',FILE='DISK015:[03BOS1.03BOS1451]KE1451A.;5',USER='RLEWIS',CD='28-MAR-2003;23:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="03BOS1451_3">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_ke1451_1">EXHIBIT 10.43</A></FONT><BR>
</UL>
<!-- SEQ=,FILE='QUICKLINK',USER=RHOOKER,SEQ=,EFW="2106012",CP="ARQULE",DN="3" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
